The Pricing Nobody Talks About
Every GLP-1 marketing funnel leads with the starting price — the cost at 0.25mg semaglutide or 2.5mg tirzepatide, the lowest dose on the titration ladder. That price gets you in the door. But most patients spend 80–90% of their time on a GLP-1 at maintenance dose — the dose where weight loss has stabilized and the medication is managing appetite long-term.
Maintenance dose varies by patient, but for semaglutide it typically lands at 1.0–2.4mg, and for tirzepatide at 5–15mg. At providers with tiered pricing, the maintenance-dose cost can be 40–100% higher than the starting price. That is the number that determines your actual annual spend.
Flat-Rate Providers: Same Price Forever
The simplest maintenance-dose story comes from providers with flat pricing. Your bill at 0.25mg is identical to your bill at 2.4mg. No surprises. No escalation.
$179/month at every dose, every month. The maintenance price is the starting price. Annual projection: $2,148.
$99/month flat. Maintenance at 2.4mg costs the same as starting at 0.25mg. Annual projection: $1,188.
$99/month flat on annual billing. No dose-based increases. Annual projection: $1,188.
Pricing is commitment-based, not dose-based. At $49/month on the 12-month plan, maintenance costs the same as titration. Annual projection: $588 (12-mo plan).
Tiered Providers: What Maintenance Actually Costs
Tiered providers advertise low starting prices but increase charges as your dose escalates. Here is what maintenance typically looks like:
| Provider | Starting Price | Maintenance (1.7–2.4mg) | Annual at Maintenance |
|---|---|---|---|
| Embody | $149/mo | $299/mo | $3,588 |
| Yucca Health | $149/mo | ~$289/mo | ~$3,468 |
| Sunlight | $159/mo | $179/mo | $2,148 |
| Found Health | $189/mo + $99 mem | $189/mo + $99 mem | $3,456 |
| Sprout Health | $229/mo | ~$269/mo | ~$3,228 |
At Embody, the starting price of $149 doubles to $299 at maintenance dose — a $1,800/year difference from what the first-month price implies. That is not a criticism of Embody's program (which includes metabolic reporting and clinical guidance), but it is a number every prospective patient should see before enrolling.
💡 The most important number in GLP-1 pricing is your maintenance-dose monthly cost multiplied by 12. That is your annual spend. Every other number — introductory rates, first-month promos, starter discounts — is temporary.
Brand-Name Maintenance Pricing
For context, here is what brand-name programs charge at maintenance doses:
| Program | Starting Dose | Maintenance Dose | Annual at Maintenance |
|---|---|---|---|
| NovoCare Wegovy (injection) | $199/mo (first 2 fills) | $349/mo | $3,988* |
| NovoCare Wegovy (oral) | $149/mo | $299/mo | $3,388* |
| LillyDirect Zepbound vials | $299/mo | $449/mo | $5,188* |
| Medicare Bridge | $50/mo | $50/mo | $600 |
*Includes 2 months at intro pricing, then 10 months at maintenance. The Medicare Bridge, at $50 flat, is the clear winner for eligible beneficiaries.
The Maintenance Math: Flat vs. Tiered Over 3 Years
Most GLP-1 patients stay on medication for 1–3+ years. The maintenance-dose cost difference between flat and tiered providers compounds dramatically over time:
| Provider Type | Monthly | Year 1 | Year 2 | Year 3 | 3-Year Total |
|---|---|---|---|---|---|
| Flat @ $99/mo | $99 | $1,188 | $1,188 | $1,188 | $3,564 |
| Flat @ $179/mo | $179 | $2,148 | $2,148 | $2,148 | $6,444 |
| Tiered (intro $149 → maint $299) | $149→$299 | $2,988* | $3,588 | $3,588 | $10,164 |
*Year 1 assumes 4 months at intro, 8 at maintenance. A flat-rate provider at $99 saves $6,600 over three years versus a tiered provider whose maintenance rate is $299 — the price of a used car.
What Determines Your Maintenance Dose?
Your prescriber determines your maintenance dose based on several factors:
- Weight-loss response. If you are losing weight steadily at 1.0mg, your prescriber may hold you there rather than titrating higher.
- Side-effect tolerance. Higher doses produce more nausea, constipation, and other GI side effects in some patients. Your maintenance dose is the highest dose where benefits outweigh discomfort.
- Goal weight. Some patients reach their target weight at moderate doses and transition to maintenance before hitting the maximum.
- Long-term sustainability. Maintenance is not temporary — most patients remain on GLP-1 medication indefinitely to maintain weight loss. The dose must be tolerable and affordable for the long term.
💡 The median maintenance dose for semaglutide in clinical practice is approximately 1.7mg — not the maximum 2.4mg. Many patients find their sweet spot below the top dose. When evaluating tiered pricing, calculate your cost at 1.7mg, not just at 2.4mg, for a more realistic projection.
Strategies for Minimizing Maintenance Costs
- Choose flat-rate from the start. If you plan to be on GLP-1 medication long-term (most patients do), selecting a flat-rate provider at enrollment eliminates dose-creep pricing entirely.
- Negotiate at renewal. If you have been with a tiered provider for 6+ months, call and ask about loyalty pricing. Retention is worth more to them than the price difference.
- Explore oral formats. Some providers price oral semaglutide or tirzepatide below injectable rates. If your prescriber supports it, switching formats can reduce maintenance costs.
- Review annually. The GLP-1 market is still compressing. A maintenance rate that was competitive 12 months ago may be above market today. Check our comparison board annually.
- Stack HSA/FSA. Maintenance is a recurring medical expense. Funding it from pre-tax health savings reduces the after-tax cost by 22–37%.
The Bottom Line
The starting price is the hook. The maintenance-dose price is the commitment. Over a multi-year treatment period, the difference between a $99/month flat-rate provider and a $299/month tiered-maintenance provider exceeds $7,000. That gap makes flat-rate pricing the single most important feature to look for when choosing a GLP-1 provider — more important than brand, more important than first-month promos, more important than anything else on the feature list.
⚠️ Compounded GLP-1 medications are not FDA-approved. Long-term maintenance on any GLP-1 medication should be monitored by a licensed clinician with periodic metabolic evaluations. Never adjust your dose without medical guidance.